HLA-B*27 is a genetic risk factor for seronegative spondyloarthropathies, such as ankylosing spondylitis, reactive arthritis, juvenile rheumatoid arthritis and anterior uveitis. ViennaLab HLA-B27 assays detect the majority of currently known HLA-B*27 variants except some rare alleles.
HLA-B27
- Ankylosing spondylitis (AS), also known as Bechterew´s disease is the most prevalent spondyloarthropathy. Symptoms at the onset of the disease are usually nonspecific, posing difficulties for a firm diagnosis.
- HLA-B molecules play an important role in immunity. Studies showed a high correlation of HLA-B*27 alleles and AS patients. Differentiating between HLA-B*27 positive and negative patients is therefore an important parameter for diagnosing spondyloarthropathies.
- Early and adequate treatment ameliorates the course of the disease.
Citations:
1. Pobisova A., et al., 2025. Distribution of human leukocyte antigen B27 (HLA-B27) in Slovak patients. Journal of applied biomedicine vol. 23,1: 36-44. doi:10.32725/jab.2025.004.
2. Özdemir Erdoğan M., et al., 2016. Association of rs11209032 and rs1004819 Polymorphisms in Interleukin-23 Receptor Gene With Ankylosing Spondylitis. Archives of rheumatology vol. 31,3: 201-207. doi:10.5606/ArchRheumatol.2016.5827.
